Phase IV Observational Study in Chronic Lymphocytic Leukemia

计划入组 1 人 · 首次发布于 2011 年 10 月 17 日

ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent

计划入组 86 人 · 首次发布于 2017 年 4 月 26 日

Cartesia eXTend 3D Study

计划入组 58 人 · 首次发布于 2020 年 10 月 8 日

CD229 CAR T cell therapy(Carterra)

CarThera

Anti-α-11(Cartela)

CARTHERA

France

CORTERIA PHARMACEUTICALS

France

UNIVERSITY OF CANBERRA

Australia

Leerink Partners Report Names Carterra a Core Enabler of the $7B "Lab-in-the-Loop" Antibody Discovery Market

London Biotechnology Show 2025 Returns with Expanded Platform for Industry Innovation and Collaboration

Jimmy Carter's Melanoma Treatment Journey Revolutionizes Immunotherapy Acceptance in Cancer Care